loading page

COVID-19 Severity Prediction in SARS-CoV-2 RNA-Positive Patients by Different Ensemble Learning Strategies
  • Emek GÜLDOĞAN,
  • Mehmet KIVRAK,
  • Cemil Colak
Emek GÜLDOĞAN
Inonu University

Corresponding Author:[email protected]

Author Profile
Mehmet KIVRAK
Inonu Universitesi Tip fakultesi
Author Profile
Cemil Colak
Inonu Universitesi Tip fakultesi
Author Profile

Abstract

Objective: While the coronavirus persists marginally for ninety-five percent of the infected case count, the remaining five percent have been placed in a critical or vital condition. This study investigates to design an intelligent model that predicts the disease severity level by modeling the relationships between the severity of COVID-19 infection and the various demographic/clinical characteristics of individuals. Material and Methods: A public dataset of a cross-sectional study included the demographic and symptomatological characteristics of 223 COVID-19 patients. The dataset was randomly divided into training (75%) and testing (25%) datasets. During training, the class imbalance problem was solved, and the related factors with the COVID-19 severity were selected using the evolutionary method supported by a genetic algorithm. Neural Network (NN), Support Vector Machine (SVM), QUEST algorithms together with confidence weighted voting, voting, and highest confidence wins strategies (HCWS) were constructed, and the predictive power of models was evaluated by performance metrics. Results: Of the individual models, the NN model outperformed SVM and QUEST algorithms based on the performance metrics in the training and testing datasets. However, ensemble approaches gave better predictions as compared to the individual models regarding all the evaluation metrics. Conclusions: The proposed voting ensemble model outperforms other ensemble and individual machine learning approaches for the severity prediction of COVID-19 disease. The proposed ensemble learning model can be integrated into web or mobile applications in classifying the severity of COVID-19 for clinical decision support.